The ratio between SARS-CoV-2 RNA viral load and culturable viral titre differs depending on the stage of infection: a case study of household transmission in an adult male
Authors:
- Michael K. PorterMPMichael K. Porter
- Alexander Viloria WinnettAWAlexander Viloria Winnett
- Linhui HaoLHLinhui Hao
- Natasha ShelbyNSNatasha Shelby
- Jessica A. ReyesJRJessica A. Reyes
- Noah W. SchlenkerNSNoah W. Schlenker
- Anne E. RomanoARAnne E. Romano
- Colton TognazziniCTColton Tognazzini
- Matthew FeasterMFMatthew Feaster
- Ying-Ying GohYGYing-Ying Goh
- Michael Gale Jr JrMJMichael Gale Jr Jr
- Rustem F. IsmagilovRIRustem F. Ismagilov
Open Access
- 1 February 2025
- journal article
- case report
- Published by Microbiology Society in Access Microbiology
- Vol. 7 (2) , 000732.v3
Abstract
Effective public health measures for communicable diseases rely on the ability to identify infectious individuals and prevent transmission from those individuals. For severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the presence of replication-competent virus in specimens from an individual is the gold standard for confirming infectiousness. However, viral culture from clinical specimens is difficult and infrequently performed. Instead, infectiousness may be inferred based on the abundance of viral RNA (or viral load) in a specimen, which is more easily assessed. For this reason, understanding the relationship between RNA viral load and infectious viral titre has important implications for public health strategy. In this case report, we quantified incident, longitudinal SARS-CoV-2 viral loads collected from saliva and nasal-swab specimens, and viral titre from nasal-swab specimens. We observed that the relationship between viral load and viral titre decreases by over five orders of magnitude throughout the course of the infection. Our work demonstrates the potential for infectious virus even in specimens with low viral loads collected during the early phases of infection.Keywords
All Related Versions
Funding Information
- Bill and Melinda Gates Foundation (INV-023134)
- Ronald and Maxine Linde Center for New Initiatives, California Institute of Technology
- Jacobs Institute, California Institute of Technology
- David Geffen School of Medicine, University of California, Los Angeles
- Foundation for the National Institutes of Health (AI151698)
- National Institutes of Health (F30AI167524)
This publication has 40 references indexed in Scilit:
- Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort studyThe Lancet Respiratory Medicine, 2022
- Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohortClinical Microbiology and Infection, 2022
- Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousnessNature Microbiology, 2022
- Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and SeverityJAMA Network Open, 2022
- Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation studyThe Lancet Microbe, 2021
- Variable duration of viral shedding in cancer patients with coronavirus disease 2019 (COVID-19)Infection Control & Hospital Epidemiology, 2021
- Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)Nature Communications, 2021
- SARS-CoV-2 detection, viral load and infectivity over the course of an infectionJournal of Infection, 2020
- Stability of SARS-CoV-2 in different environmental conditionsThe Lancet Microbe, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020